Ellume Limited (Ellume or the Company), a digital healthcare and medical diagnostics company, is pleased to announce a strategic partnership with GSK Consumer healthcare, one of the world’s leading over-the-counter healthcare companies, to explore the development of digital consumer products.
Brisbane, Australia – 13 December 2018
Ellume Limited (Ellume or the Company), a digital healthcare and medical diagnostics company, is pleased to announce a strategic partnership with GSK Consumer healthcare, one of the world’s leading over-the-counter healthcare companies, to explore the development of digital consumer products.
Ellume is focused on developing innovative products which enable effective and efficient healthcare for common, burdensome illness where early accurate diagnosis could significantly improve patient outcomes. Ellume products are distinguished by their technical performance, ease of use, rapid time to result and connectivity.
Commenting on the strategic partnership, Ellume’s Founder and Managing Director, Dr Sean Parsons said, “At Ellume, we pride ourselves on creating new products based on world-class science and technology, so we’re pleased to be partnering with the global leader in the field to bring this great science to a global audience where it can have maximum impact on people’s lives.”
Investors
Dr Sean Parsons
Founder & Managing Director
E: sean.parsons@ellumehealth.com
T: +61 7 3393 1448
Media & General Inquiries
Ben Walsh
WE Buchan
E: bwalsh@we-buchan.com
M: +61 411 520 012
About GlaxoSmithKline (GSK)
GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. For further information please visit www.gsk.com/about-us.
About Ellume
Through the creation of simple, accurate digital diagnostic tools, and through the linking of the results of those tools to the best treatments, we enable people to get better sooner and enjoy their lives. For further information please visit www.ellumehealth.com.
